Cefadroxil - NDC Database (Page 4)
63304-972 Aug 30, 2005
Cefadroxil 125 mg/5ml Oral Powder, for Suspension by Ranbaxy Pharmaceuticals Inc.
Cefadroxil 125 mg/5ml Oral Powder, for Suspension by Ranbaxy Pharmaceuticals Inc.
63304-973 Aug 30, 2005
Cefadroxil 250 mg/5ml Oral Powder, for Suspension by Ranbaxy Pharmaceuticals Inc.
Cefadroxil 250 mg/5ml Oral Powder, for Suspension by Ranbaxy Pharmaceuticals Inc.
63304-974 Aug 30, 2005
Cefadroxil 500 mg/5ml Oral Powder, for Suspension by Ranbaxy Pharmaceuticals Inc.
Cefadroxil 500 mg/5ml Oral Powder, for Suspension by Ranbaxy Pharmaceuticals Inc.
65862-083 Apr 25, 2013
Cefadroxil 250 mg/5ml Oral Powder, for Suspension by Aurobindo Pharma Limited
Cefadroxil 250 mg/5ml Oral Powder, for Suspension by Aurobindo Pharma Limited
65862-084 Apr 25, 2013
Cefadroxil 500 mg/5ml Oral Powder, for Suspension by Aurobindo Pharma Limited
Cefadroxil 500 mg/5ml Oral Powder, for Suspension by Aurobindo Pharma Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.